Hyderabad-based pharmaceutical company, Dr. Reddy’s Laboratories Ltd, has partnered with US-based enterprise technology provider, Kyndryl, to transform its IT operations across all locations, including manufacturing plants, international sites, datacenters, cloud operations, and offices. As part of this partnership, Kyndryl will utilize its AI-powered digital business platform, Kyndryl Bridge, to automate the monitoring of Dr. Reddy’s hybrid computing landscape, and leverage actionable insights for failure prediction and prevention, auto remediation, self-healing, and self-help features.
The partnership aims to reduce manual interventions by about 60% through intelligent automation of operations, providing a single-pane analytics and IT dashboard that improves visibility into IT operations, including service performance, compliance posture, and risk controls. This will enable digital-led compliance and governance models, optimizing operational efficiency, enhancing regulatory compliance, agility, and end-user experience.
According to Lingraju Sawkar, President, Kyndryl India, the company’s advanced technology and expertise will support Dr. Reddy’s Laboratories’ digital transformation journey. The new operations model will achieve this by optimizing IT operations, reducing manual interventions, and providing real-time insights into IT performance, compliance, and risk controls.
The partnership is a significant step towards Dr. Reddy’s Laboratories’ digital transformation, and Kyndryl’s expertise in providing AI-powered open integration digital business platform, Kyndryl Bridge, will be instrumental in achieving this goal. With this partnership, Dr. Reddy’s Laboratories is poised to reap the benefits of a more efficient, agile, and digitally transformed IT environment, which will ultimately improve its competitiveness in the pharmaceutical industry.